Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $217 - $239
3 Added 0.8%
376 $29,000
Q1 2022

May 03, 2022

BUY
$61.48 - $73.72 $2,582 - $3,096
42 Added 12.69%
373 $27,000
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $164,268 - $191,498
-3,063 Reduced 90.25%
331 $21,000
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $1,065 - $1,247
18 Added 0.53%
3,394 $201,000
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $1,176 - $1,280
19 Added 0.57%
3,376 $226,000
Q1 2021

May 04, 2021

BUY
$59.34 - $66.74 $1,127 - $1,268
19 Added 0.57%
3,357 $212,000
Q4 2020

Jan 21, 2021

BUY
$57.74 - $65.43 $1,039 - $1,177
18 Added 0.54%
3,338 $207,000
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $1,091 - $1,209
19 Added 0.58%
3,320 $200,000
Q2 2020

Jul 24, 2020

BUY
$54.82 - $64.09 $48,022 - $56,142
876 Added 36.12%
3,301 $194,000
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $788 - $1,146
17 Added 0.71%
2,425 $135,000
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $836 - $1,091
17 Added 0.71%
2,408 $154,000
Q3 2019

Oct 15, 2019

BUY
$42.77 - $50.71 $898 - $1,064
21 Added 0.89%
2,391 $121,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $14,679 - $16,232
-329 Reduced 12.19%
2,370 $107,000
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $857 - $1,022
19 Added 0.71%
2,699 $129,000
Q4 2018

Jan 18, 2019

BUY
$48.76 - $63.23 $828 - $1,074
17 Added 0.64%
2,680 $139,000
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $36,590 - $41,271
663 Added 33.15%
2,663 $165,000
Q2 2018

Jul 26, 2018

SELL
$50.53 - $62.98 $1.37 Million - $1.71 Million
-27,150 Reduced 93.14%
2,000 $110,000
Q1 2018

Apr 23, 2018

SELL
$59.92 - $68.98 $58,721 - $67,600
-980 Reduced 3.25%
29,150 $1.84 Million
Q4 2017

Jan 29, 2018

BUY
$59.94 - $65.35 $3,896 - $4,247
65 Added 0.22%
30,130 $1.85 Million
Q3 2017

Nov 03, 2017

SELL
$55.23 - $63.74 $45,399 - $52,394
-822 Reduced 2.66%
30,065 $1.92 Million
Q2 2017

Aug 09, 2017

BUY
N/A
30,887
30,887 $1.72 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sterling Investment Advisors, Ltd. Portfolio

Follow Sterling Investment Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.